Novartis Pharmaceuticals Corporation et al v. Dr. Reddys Laboratories, Inc. et al
| Novartis Pharmaceuticals Corporation and Dana-Farber Cancer Institute, Inc. |
| Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. |
| 1:2021cv01106 |
| July 29, 2021 |
| US District Court for the District of Delaware |
| Leonard P Stark |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
This docket was last retrieved on September 23, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pro Hac Vice Attorneys Constance S. Huttner and Beth C. Finkelstein for Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Pro Hac Vice Attorneys Kyanna Sabanoglu, Anne Y. Brody, Ronald A. Lee, Sung Bin Lee for Dana-Farber Cancer Institute, Inc. and Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:21-cv-01105-LPS, 1:21-cv-01106-LPS, 1:21-cv-01107-LPS(srs) |
| Pro Hac Vice Attorney Jane M. Love for Dana-Farber Cancer Institute, Inc. and Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:21-cv-01105-LPS, 1:21-cv-01106-LPS, 1:21-cv-01107-LPS(srs) |
|
|
|
|
| Filing 12 MOTION for Pro Hac Vice Appearance of Attorney Jane M. Love, Kyanna Sabanoglu, Sung Bin Lee, Anne Y. Brody, and Ronald A. Lee - filed by Dana-Farber Cancer Institute, Inc., Novartis Pharmaceuticals Corporation. (Attachments: #1 Certifications for Jane M. Love, Kyanna Sabanoglu, Sung Bin Lee, Anne Y. Brody, and Ronald A. Lee)(Silver, Daniel) |
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Constance S. Huttner and Beth C. Finkelstein - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Attachments: #1 Certification, #2 Certification)(Ormerod, Eve) |
| Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Dr. Reddys Laboratories, Ltd. for Dr. Reddy's Laboratories, Inc. filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Belgam, Neal) |
| Filing 9 ANSWER to #1 Complaint, and Additional Defenses by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(Ormerod, Eve) |
|
|
| Filing 8 STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint from August 20, 2021 to September 3, 2021 - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Ormerod, Eve) |
| Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:21-cv-01105-LPS, 1:21-cv-01106-LPS, 1:21-cv-01107-LPS (rjb) |
| Filing 7 Summons Issued with Magistrate Consent Notice attached as to Dr. Reddy's Laboratories, Inc. on 7/30/2021; Dr. Reddy's Laboratories, Ltd. on 7/30/2021. (Attachments: #1 Summons Issued)(myr) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (myr) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Dana-Farber Cancer Institute, Inc. (myr) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,973,031. (myr) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No Earlier than June 16, 2021. Date of Expiration of Patent: No earlier than July 13, 2025.Thirty Month Stay Deadline: No Earlier than 12/16/2023. (myr) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Filing 1 COMPLAINT filed against Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3668327.) - filed by Novartis Pharmaceuticals Corporation, Dana-Farber Cancer Institute, Inc. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(myr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.